BeiGene (NASDAQ: BGNE)
BeiGene Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
BeiGene Company Info
BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
News & Analysis
Why BeiGene Stock Jumped Thursday
A collaboration deal helped send the Chinese biotech stock higher.
Why Shares of BeiGene Are Up Wednesday
The Chinese pharmaceutical stock is experiencing a comeback.
Is This Chinese Pharmaceutical Stock Worth the Risk?
BeiGene's shares are down this year, but it has two potential blockbusters.
Why Shares of BeiGene Popped Today
Regulators in China agreed to start the review process for one of its medicines.
This Chinese Stock Could Skyrocket 85%, According to Wall Street
The most critical hurdle confronting the biotech is avoiding having its shares delisted by the SEC.
Why BeiGene Stock Soared 33.7% on Wednesday
The Chinese pharmaceutical company saw a bounce back after positive news from government officials.
Why Shares of BeiGene and Zai Lab Are Tanking Today
The threat of a forced delisting is weighing heavily on these two Chinese biotech stocks.
Why BioGene's Shares Jumped on Friday
The Chinese pharmaceutical company is racking up approvals for its lead oncology drug, Brukinsa.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.